Lilrincan 100mg Injection
Marketer
Eli Lilly and Company India Pvt Ltd
Salt Composition
Irinotecan (100mg)
Overview Lilrincan 100mg Injection
Oncasin 100mg Injection treats colorectal cancer by inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include tiredness, nausea, vomiting, weakness, and alopecia. This medication can lower blood cell counts (red and white), raising infection risk. Report fever, sore throat, or persistent diarrhea immediately. Regular blood tests monitor blood cell levels, alongside heart, liver, and uric acid. Prior to treatment, disclose any heart, liver, or kidney conditions, and all medications, particularly those for infections, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is crucial throughout treatment.
Uses of Lilrincan 100mg Injection
Colorectal cancer
Major Benefits of Lilrincan 100mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Lilrincan 100mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Lilrincan 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lilrincan 100mg Injection works:
Oncaspar 100mg injection is a cancer treatment that inhibits topoisomerase I, an enzyme crucial for DNA replication in cancerous cells. This action curtails cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lilrincan 100mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Lilrincan 100mg Injection during gestation poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Lilrincan 100mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administration of Lilrincan 100mg Injection might cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Lilrincan 100mg Injection in individuals with kidney impairment is likely safe, with existing evidence indicating dose modification may be unnecessary. However, physician consultation is advised. This medication is contraindicated for patients undergoing dialysis.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Lilrincan 100mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Lilrincan 100mg Injection :
Omit a dose of Lilrincan 100mg Injection? Seek your physician's advice.
Facts to Know About Lilrincan 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Topoisomerase inhibitor |
3,018 People bought this recently